SB 876: Chimeric Antigen Receptor T-cell Therapy
GENERAL BILL by Berman
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
-
Bill History
Date Chamber Action 2/19/2025 Senate • Filed
-
SB 876, Original Filed Version (Current Bill Version) Posted 2/19/2025 at 9:52 AM
Bill Text: Web Page | PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills H 725 Health Insurance Coverage for CAR T-Cell Therapies Rayner Compare Last Action: 2/19/2025 H Filed Citations - Statutes (3)
Citation Catchline Location in Bill Location In Bill Help 627.64198 Page 1 (pdf) 627.6614 Page 1 (pdf) 641.31078 Page 2 (pdf)